Загрузка...
Immune Checkpoint Inhibitor-induced Fanconi Syndrome
Immune checkpoint inhibitors (ICI) have been approved by the Food and Drug Administration (FDA) for use in many solid tumors and hematological malignancies. Immune-related adverse events (irAEs) are potential side effects that can arise during or after treatment with ICI therapy. We describe a case...
Сохранить в:
| Опубликовано в: : | Cureus |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Cureus
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7233517/ https://ncbi.nlm.nih.gov/pubmed/32431966 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.7686 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|